Stevens, N. E., Chapman, M. J., Fraser, C. K., Kuchel, T. R., Hayball, J. D., & Diener, K. R. (2017). Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes. Sci Rep.

Stevens, Natalie E., Marianne J. Chapman, Cara K. Fraser, Tim R. Kuchel, John D. Hayball, i Kerrilyn R. Diener. "Therapeutic Targeting of HMGB1 During Experimental Sepsis Modulates the Inflammatory Cytokine Profile to One Associated With Improved Clinical Outcomes." Sci Rep 2017.

Stevens, Natalie E., et al. "Therapeutic Targeting of HMGB1 During Experimental Sepsis Modulates the Inflammatory Cytokine Profile to One Associated With Improved Clinical Outcomes." Sci Rep 2017.